Skip to main content
Premium Trial:

Request an Annual Quote

BD's MRSA Assay Receives Moderate Complexity Rating Under CLIA

NEW YORK (GenomeWeb News) – Becton Dickinson segment BD Diagnostics said today its BD Max MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988.

The rating allows the test to be performed by a qualified laboratory technician.

The assay was cleared by the US Food and Drug Administration last month for marketing in the US. It runs on the fully automated BD Max System and was developed to rapidly identify patients with methicillin-resistant Staphylococcus aureus.

"Healthcare institutions can now simplify and optimize their MRSA active surveillance testing in less than a minute of hands-on time per specimen with true walk-away automation," Tom Polen, president of BD Diagnostics, said in a statement.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.